Tumour Models Summit Nordics focuses on discussing the latest advancements and strategies in selecting and optimizing tumour models to enhance drug development, biomarker discovery, and clinical translatability.
Topics
- 3D In Vitro Models
- Humanised Mouse Models
- Advanced Omics Data
- Target/Receptor Axis Modelling
- Innovative DNA-Targeting Mechanisms for Solid Tumours
- In Vivo and In Vitro Tumour Modelling
- Biomarker Discovery and Therapeutic Development
- Optimizing Drug Development Pipelines
Who should Attend
- Pharma and biotech professionals
- Researchers and academics in cancer biology
- Leaders in preclinical and translational research
- Drug development specialists
- Experts in tumour modelling and cancer therapeutics
- Decision-makers in the biotech and pharmaceutical industries
